Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design

Tabernero Caturla, Josep; Prager, Gerald W; Leger, Catherine; Fakih, Marwan; Taieb, Julien; Ciardiello, Fortunato

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Tabernero Caturla, Josep
dc.contributor.author	Prager, Gerald W
dc.contributor.author	Leger, Catherine
dc.contributor.author	Fakih, Marwan
dc.contributor.author	Taieb, Julien
dc.contributor.author	Ciardiello, Fortunato
dc.date.accessioned	2021-07-09T12:37:00Z
dc.date.available	2021-07-09T12:37:00Z
dc.date.issued	2021-06
dc.identifier.citation	Tabernero J, Taieb J, Prager GW, Ciardiello F, Fakih M, Leger C, et al. Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design. Futur Oncol. 2021 Jun;17(16):1977–1985.
dc.identifier.issn	1744-8301
dc.identifier.uri	https://hdl.handle.net/11351/6146
dc.description	Bevacizumab; Càncer colorectal metastàtic; Trifluridine/tipiracil
dc.language.iso	eng
dc.publisher	Future Medicine
dc.relation.ispartofseries	Future Oncology;17(16)
dc.rights	Attribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.source	Scientia
dc.subject	Medicaments antineoplàstics - Ús terapèutic
dc.subject	Recte - Càncer
dc.subject	Còlon - Càncer
dc.subject.mesh	Colorectal Neoplasms
dc.subject.mesh	Antineoplastic Combined Chemotherapy Protocols
dc.subject.mesh	/therapeutic use
dc.title	Trifluridine/tipiracil plus bevacizumab for third-line management of metastatic colorectal cancer: SUNLIGHT study design
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.2217/fon-2020-1238
dc.subject.decs	neoplasias colorrectales
dc.subject.decs	protocolos de quimioterapia antineoplásica combinada
dc.subject.decs	/uso terapéutico
dc.relation.publishversion	https://www.futuremedicine.com/doi/10.2217/fon-2020-1238
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Tabernero J] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Institute of Oncology (VHIO), Barcelona, Spain. [Taieb J] Service d'hépatogastroentérologie et d'oncologie digestive, Université de Paris, Paris Descartes University, Georges Pompidou European Hospital, 20 rue Leblanc, Paris, France. [Prager GW] Department of Medicine I, Comprehensive Cancer Centre Vienna, Medical University Vienna, Josefstaedter Str. 23/15, Vienna, Austria. [Ciardiello F] Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Via S. Pansini, Naples, Italy. [Fakih M] Briskin Center for Clinical Research, Section Head and GI Medical Oncology, City of Hope Comprehensive Cancer Center, 1500 E Duarte St, Duarte, CA, USA. [Leger C] Institut de Recherches Internationales Servier, 50 rue Carnot, Suresnes Cedex, France
dc.identifier.pmid	33569986
dc.identifier.wos	000616966800001
dc.rights.accessrights	info:eu-repo/semantics/openAccess